Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAIV Immuno: Fluenz Safety and Immunogenicity in Children
NCT02143882Phase 4Completed
- Sponsor
- UK Health Security Agency
- Start
- Sep 2014
- Primary completion
- Mar 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of live attenuated influenza vaccine in influenza, sponsored by UK Health Security Agency. Started Sep 2014; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02143882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02143882.